See more : Gabungan AQRS Berhad (5226.KL) Income Statement Analysis – Financial Results
Complete financial analysis of Humedix Co., Ltd. (200670.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Humedix Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Vert Infrastructure Ltd. (CRXPF) Income Statement Analysis – Financial Results
- Ono Pharmaceutical Co., Ltd. (4528.T) Income Statement Analysis – Financial Results
- Orange Electronic Co., Ltd. (4554.TWO) Income Statement Analysis – Financial Results
- Euroz Hartleys Group Limited (EZL.AX) Income Statement Analysis – Financial Results
- Najran Cement Company (3002.SR) Income Statement Analysis – Financial Results
Humedix Co., Ltd. (200670.KQ)
About Humedix Co., Ltd.
Humedix Co., Ltd., a healthcare company, researches, develops, manufactures, and sells various pharmaceutical products in South Korea. It offers over-the-counter drugs, prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic products, and functional synthetic materials, as well as health functional foods. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. The company was founded in 2002 and is headquartered in Anyang-si, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 152.27B | 123.17B | 110.99B | 98.48B | 78.62B | 64.83B | 54.73B | 47.13B | 42.13M |
| Cost of Revenue | 81.92B | 70.18B | 68.93B | 60.45B | 46.90B | 39.74B | 30.59B | 24.87B | 20.46M |
| Gross Profit | 70.35B | 52.99B | 42.06B | 38.03B | 31.72B | 25.09B | 24.13B | 22.26B | 21.67M |
| Gross Profit Ratio | 46.20% | 43.02% | 37.90% | 38.62% | 40.34% | 38.70% | 44.10% | 47.23% | 51.43% |
| Research & Development | 9.77B | 9.72B | 9.10B | 7.50B | 5.73B | 4.96B | 4.63B | 4.69B | 3.32M |
| General & Administrative | 2.92B | 2.53B | 2.45B | 1.90B | 7.70M | 5.53M | 4.51M | 2.80M | 2.48M |
| Selling & Marketing | 9.80B | 6.71B | 6.99B | 4.94B | 5.22M | 3.75M | 3.05M | 1.84M | 1.65M |
| SG&A | 12.72B | 18.02B | 17.52B | 14.03B | 12.96B | 9.37B | 7.63B | 4.67B | 4.13M |
| Other Expenses | 10.23B | -66.04M | -96.91M | -66.78M | -95.94M | -65.51M | -76.16M | -70.96M | 0.00 |
| Operating Expenses | 33.04B | 27.81B | 26.71B | 21.60B | 18.78B | 14.40B | 12.34B | 9.42B | 7.73M |
| Cost & Expenses | 114.96B | 97.99B | 95.64B | 82.05B | 65.68B | 54.14B | 42.93B | 34.29B | 28.19M |
| Interest Income | 2.77B | 1.75B | 508.14M | 297.53M | 364.76M | 402.40K | 389.07K | 901.84K | 1.04M |
| Interest Expense | 1.45B | 3.17B | 2.23B | 257.14M | 44.41M | 136.08M | 140.49M | 506.31K | 23.37M |
| Depreciation & Amortization | 11.28B | 11.49B | 12.27B | 10.52B | 8.88B | 7.11B | 4.24B | 2.24B | 1.50M |
| EBITDA | 45.13B | 49.00B | 31.13B | 30.62B | 22.16B | 19.06B | 20.81B | 14.71B | 16.51B |
| EBITDA Ratio | 29.64% | 29.77% | 24.89% | 27.37% | 27.75% | 27.45% | 29.30% | 31.98% | 36.91% |
| Operating Income | 37.31B | 25.18B | 15.35B | 16.43B | 12.93B | 10.69B | 11.79B | 12.84B | 14.05M |
| Operating Income Ratio | 24.50% | 20.44% | 13.83% | 16.69% | 16.45% | 16.49% | 21.55% | 27.24% | 33.35% |
| Total Other Income/Expenses | -4.90B | 2.95B | -3.66B | 1.85B | -46.08M | 1.13B | 4.02B | -364.73M | 930.81M |
| Income Before Tax | 32.41B | 28.17B | 12.33B | 19.84B | 13.23B | 11.82B | 16.43B | 12.47B | 14.98M |
| Income Before Tax Ratio | 21.28% | 22.87% | 11.11% | 20.15% | 16.83% | 18.24% | 30.03% | 26.47% | 35.56% |
| Income Tax Expense | 7.59B | 7.84B | 1.29B | 3.09B | 1.02B | 1.06B | 2.63B | 2.00B | 3.36M |
| Net Income | 24.82B | 21.09B | 9.06B | 15.08B | 10.42B | 9.21B | 11.94B | 10.27B | 11.62M |
| Net Income Ratio | 16.30% | 17.12% | 8.17% | 15.32% | 13.25% | 14.20% | 21.82% | 21.80% | 27.59% |
| EPS | 2.51K | 2.27K | 963.99 | 1.59K | 1.09K | 963.24 | 1.23K | 1.06K | 1.25K |
| EPS Diluted | 2.51K | 2.27K | 963.99 | 1.59K | 1.09K | 963.24 | 1.23K | 1.06K | 1.25K |
| Weighted Avg Shares Out | 9.88M | 9.27M | 9.40M | 9.50M | 9.53M | 9.56M | 9.71M | 9.70M | 9.33K |
| Weighted Avg Shares Out (Dil) | 9.88M | 9.27M | 9.40M | 9.50M | 9.53M | 9.56M | 9.71M | 9.70M | 9.33K |
Source: https://incomestatements.info
Category: Stock Reports